Sarepta Therapeutics, Inc. (0L35.L) LSE

21.15

-0.6736(-3.09%)

Updated at August 19 06:00AM

Currency In USD

Valuation

Market Cap11.56B
Enterprise Value11.8B
P/E Ratio-35.49
PEG Ratio-0.46
Price/Sales Ratio0.83
Price/Book Ratio1.52
Enterprise/Revenue1.17
Enterprise/EBITDA65.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.02
Operating Margin-0

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue1.9B
Revenue/Share25.32
Gross Profit1.58B
EBITDA333.06M
Net Income235.24M
Diluted EPS2.34

Balance Sheet

Total Cash800.14M
Total Cash/Share8.16
Total Debt1.35B
Total Debt/Equity1
Current Ratio2.89
Book Value Per Share13.85

Price History

52-Week Change-83.97
52-Week High155.48
52-Week Low21.31
Moving Average 50 Days121.03
Moving Average 200 Days112.45

Statistics

Average Volume424
Shares Outstanding97.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A